Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Andrew Chambers currently holds 27,535 shares of Sarepta Therapeutics, Inc. (SRPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Andrew Chambers has been a net buyer of SRPT stock. They have purchased $23.3M and sold $0 worth of shares.
Michael Andrew Chambers's most recent insider trade was on Jun 4, 2026, when they sold 16,875 shares at $0.00 per share.
Michael Andrew Chambers serves as Executive at Sarepta Therapeutics, Inc. (SRPT). They have executed 19 insider transactions totaling $23.3M over their tenure at the company.
Michael Andrew Chambers holds the position of Executive at Sarepta Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Michael Andrew Chambers has shown a buying trading pattern, with $23.3M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Michael Andrew Chambers was on Aug 19, 2022, when they purchased $4.3M worth of SRPT shares. This transaction involved 40,110 shares at $108.20 per share.
Michael Andrew Chambers currently owns 27,535 shares of Sarepta Therapeutics, Inc. (SRPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Andrew Chambers's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Andrew Chambers has 19 Form 4 filings on record as an insider at Sarepta Therapeutics, Inc..
Set alerts for Michael Andrew Chambers and 40,000+ other insiders.